Evgeni Chubar

Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing

Yaël C. Cohen, Mor Zada, Shuang-Yin Wang et al. · Nature Medicine · 2021 · 246 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

Meletios Α. Dimopoulos, Paul G. Richardson, Nizar J. Bahlis et al. · The Lancet Haematology · 2022 · 47 citations

Medicine, Oncology, Pharmacotherapy +12

Targeted next generation sequencing for the diagnosis of patients with rare congenital anemias

Noa Shefer Averbuch, Orna Steinberg‐Shemer, Orly Dgany et al. · European Journal Of Haematology · 2018 · 41 citations

Medicine, Genetics, Hematology +17

Efficacy and safety of salvage therapy using Carfilzomib for relapsed or refractory multiple myeloma patients: a multicentre retrospective observational study

Eli Muchtar, Moshe E. Gatt, Ory Rouvio et al. · British Journal of Haematology · 2015 · 38 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Real-life Experience With Ponatinib in Chronic Myeloid Leukemia: A Multicenter Observational Study

Adi Shacham‐Abulafia, Pia Raanani, David Lavie et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 27 citations

Medicine, Hematology, Oncology +5